[New pharmacologic developments in physical urticaria--therapeutic consequences].
Recent evidence suggests that mast cell derived mediators other than histamine are likely to be involved in the pathogenesis of physical urticarias. Much of the work has been performed in idiopathic cold contact urticaria where the presence of neutrophil and eosinophil chemotactic factors, and platelet activating factor-like lipid substances have been previously demonstrated. Now, an increase in prostaglandin D2 measured by GC-MS has been demonstrated in venous blood draining the cold challenged area. This appeared a few minutes later than histamine, but then both substances paralleled the onset, development and subsidence of the urticarial reaction. There appeared to be no quantitative relationship between histamine and PGD2 release. A similar rise in histamine and PGD2 occurred on heat challenge of a subject with the rare localized form of heat urticaria. This rise of both substances was considerably reduced after combined treatment with induction of tolerance and oral indomethacin. The concentrations of PGD2 measured suggested that it plays an indirect role.
Greaves
M W
MW
Kobza Black
A
A
Barr
R M
RM
Heavey
D J
DJ
D003080:Cold Temperature / Q000009:adverse effects; D006632:Histamine / Q000097:blood*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D010812:Physical Stimulation; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000097:blood*; D014581:Urticaria / Q000097:blood / Q000188:drug therapy*
D011457:Prostaglandins D; D006632:Histamine; D015230:Prostaglandin D2; D007213:Indomethacin
Neuere pharmakologische Entwicklungen bei physikalischer Urtikaria--Therapeutische Konsequenzen.